HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China
HPV vaccination intent and willingness to pay for 2-,4-, and 9-valent HPV vaccines: A study of adult women aged 27-45 years in China
复制标题
DOI：
10.1016/j.vaccine.2020.02.042
复制
发表时间：
2020-03-23
期刊：
影响因子：
5.5
通讯作者：
Wong, Li Ping
中科院分区：
文献类型：
--
作者：
Lin, Yulan;Lin, Zheng;Wong, Li Ping
目的：本研究的目的是调查接受和愿意支付HPV疫苗接种成年women.Methods：在中国福建省，中国的小学生的母亲年龄在27-45岁的在线调查。调查对象填写了HPV相关知识和健康信念、接种HPV疫苗的意愿、二价HPV疫苗（2 vHPV）、四价HPV疫苗（4vHPV）和九价HPV疫苗（9vHPV）的付费意愿等问题。年龄较小，居住在城市，从事管理或专业职业，认识宫颈癌患者并且能够独立决定HPV疫苗（与配偶共同决定）的母亲更有可能表达接种HPV疫苗的意图。感知障碍、行动线索和自我效能是健康信念模型中显著影响HPV疫苗接种意图的三个结构。2 vHPV（81.2%）和4vHPV（75.9%）的受试者表示愿意付费接种HPV疫苗，而9vHPV（67.7%）的受试者表示愿意付费接种HPV疫苗。有必要采取干预措施，解决中国成年女性接种HPV疫苗的障碍。(C)2020爱思唯尔有限公司保留所有权利。
Objective: This study aims to investigate acceptance and willingness to pay for HPV vaccination among adult women in China.Methods: An online survey was sent to mothers aged 27-45 years of primary school pupils in the Fujian province, China. Participants completed questions about HPV related knowledge and health beliefs, intention to take the HPV vaccine and the willingness to pay for bivalent vaccine (2vHPV), quadrivalent vaccine (4vHPV), and 9-valent HPV vaccine (9vHPV).Results: Of a total of 2339 complete responses, 58.3% reported intent to obtain HPV vaccine. Mothers who were younger in age, residing in urban, working in managerial or professional occupations, who knew someone with cervical cancer and who were able to make independent decisions about the HPV vaccine (vs. joint decision with spouse) were more likely to express intent to have HPV vaccination. Perceived barriers, cues to action and self-efficacy were three of the constructs in the health belief model that significantly influenced HPV vaccination intent. A higher proportion of participants expressed willingness to pay for 2vHPV (81.2%) and 4vHPV (75.9%), as compared to 9vHPV (67.7%).Conclusion: Adults women expressed moderate intention to receive the HPV vaccine. Intervention to address barriers to uptake of the HPV vaccine among adult women in China is warranted. (C) 2020 Elsevier Ltd. All rights reserved.